An experimental pill from Merck was shown in a trial to cut the risk of COVID-19 hospitalization and death in half, the company has announced.
The drugmaker said Friday that in a trial, those who received its pill to treat COVID-19, molnupiravir, within five days of experiencing symptoms had half the rate of hospitalization and death as patients who received a placebo, The Associated Press reports. According to Merck, the rate of hospitalizations or deaths was 7.3 percent among those patients who received molnupiravir compared to 14.1 percent for the placebo group.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
'The disconnect between actual health care and the insurance model is widening'Instant Opinion Opinion, comment and editorials of the day
-
Cautious optimism surrounds plans for the world's first nuclear fusion power plantTalking Point Some in the industry feel that the plant will face many challenges
-
Explore new worlds this winter at these 6 enlightening museum exhibitionsThe Week Recommends Discover the estrados of Spain and the connection between art and chess in various African countries
-
US won its war on 'murder hornets,' officials saySpeed Read The announcement comes five years after the hornets were first spotted in the US
-
Dark energy data suggest Einstein was rightSpeed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
-
New DNA tests of Pompeii dead upend popular storiesSpeed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
-
NASA's Europa Clipper blasts off, seeking an oceanSpeed Read The ship is headed toward Jupiter on a yearslong journey
-
Detailed map of fly's brain holds clues to human mindSpeed Read This remarkable fruit fly brain analysis will aid in future human brain research
-
What does Covid look like in 2024?Today's Big Question Disease experts are calling for closer monitoring as new variant fuels rise in infections
-
Blind people will listen to next week's total eclipseSpeed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
-
Melting polar ice is messing with global timekeepingSpeed Read Ice loss caused by climate change is slowing the Earth's rotation
